MOMA: Bayer, MOMA Therapeutics ink collaboration to develop and commercialize small molecule oncology programme

Bayer and MOMA Therapeutics, Inc., a clinical─stage biopharmaceutical company discovering and developing a new generation of precision therapeutics, announced that they have entered into a collaboration, under